ciprofloxacin has been researched along with Endophthalmitis in 61 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 7.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "The purpose of this study was to analyze ciprofloxacin and lomefloxacin penetration into the anterior eye tissues after topical instillation in healthy rabbits and with experimental Staphylococcus aureus endophthalmitis." | 7.80 | Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis. ( Haritova, AM; Krustev, SZ; Rusenova, NV, 2014) |
| "To determine the effectiveness of intravitreal triamcinolone acetonide in the management of bacterial endophthalmitis." | 7.73 | Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. ( Das, T; Pathengay, A; Shah, GY; Sharma, S, 2006) |
| "To determine injection time and effective dose of ciprofloxacin in endophthalmitis and to evaluate the effectiveness of dexamethasone." | 7.69 | Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis. ( Chung, KH; Kim, IT; Koo, BS, 1996) |
| "The authors compare the intravitreal efficacy of ciprofloxacin, vancomycin and imipenem, in treating experimental Bacillus cereus endophthalmitis." | 7.69 | Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. ( Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ, 1996) |
| "Ciprofloxacin has been proposed for the systemic treatment of endophthalmitis." | 7.68 | The role of ciprofloxacin in endophthalmitis therapy. ( Eller, AW; Karenchak, LM; Kowalski, RP, 1993) |
| "Single intravitreal doses of ciprofloxacin, gentamicin, or imipenem were administered to rabbits with pseudomonas endophthalmitis for determination of the maximally effective dose." | 7.67 | Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections. ( Barza, M; Davey, PG; Stuart, M, 1987) |
| "Ofloxacin has the best aqueous penetration in human eyes, as compared with ciprofloxacin and tobramycin, which suggests ofloxacin could be the preferred topical medicine for the prevention and treatment of endophthalmitis." | 5.10 | [Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin]. ( Wu, XD; Yang, YH; Yao, K; Zhang, Z, 2003) |
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 3.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "The purpose of this study was to analyze ciprofloxacin and lomefloxacin penetration into the anterior eye tissues after topical instillation in healthy rabbits and with experimental Staphylococcus aureus endophthalmitis." | 3.80 | Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis. ( Haritova, AM; Krustev, SZ; Rusenova, NV, 2014) |
| "Retrospective review of all patients with suspected endophthalmitis after intravitreal injections treated with intravitreal antibiotics (teicoplanin and ciprofloxacin) at a referral centre between January 2003 and December 2010." | 3.78 | Endophthalmitis following intravitreal injections. ( Heimann, H; Irigoyen, C; Morphis, G; Stappler, T; Ziahosseini, K, 2012) |
| "To determine the effectiveness of intravitreal triamcinolone acetonide in the management of bacterial endophthalmitis." | 3.73 | Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. ( Das, T; Pathengay, A; Shah, GY; Sharma, S, 2006) |
| " The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously." | 3.72 | [Recurrence of bacterial endophthalmitis after penetrating keratoplasty]. ( Domínguez, I; García Serrano, JL; Serrano Laborda, D, 2004) |
| "To determine the in vitro efficacy of levofloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae and Streptococcus viridans isolates recovered from clinical cases of keratitis and endophthalmitis." | 3.72 | Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates. ( Alfonso, EC; Miller, D, 2004) |
| "Neisseria gonorrhoeae infection in the eye and its treatment with ciprofloxacin is presented." | 3.71 | Gonococcal ophthalmia treated with ciprofloxacin. ( O'Mahony, C; Price, LM, 2001) |
| "To determine injection time and effective dose of ciprofloxacin in endophthalmitis and to evaluate the effectiveness of dexamethasone." | 3.69 | Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis. ( Chung, KH; Kim, IT; Koo, BS, 1996) |
| "The objective of this work was to evaluate various methods of sustained delivery to achieve therapeutic intravitreal levels of ciprofloxacin as a potential therapy for endophthalmitis." | 3.69 | Intravitreal delivery of ciprofloxacin. ( Ashton, P; Ax, D; Bierly, JR; Conklin, JD; Hainsworth, DP, 1996) |
| "The authors compare the intravitreal efficacy of ciprofloxacin, vancomycin and imipenem, in treating experimental Bacillus cereus endophthalmitis." | 3.69 | Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. ( Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ, 1996) |
| "The study demonstrated that the combination of vancomycin, amikacin, and ciprofloxacin is adequate as a standard regimen for the treatment of most patients with suspected bacterial endophthalmitis." | 3.69 | Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. ( Hykin, P; Lightman, S; Matheson, M; Okhravi, N; Towler, HM, 1997) |
| "Ciprofloxacin has been proposed for the systemic treatment of endophthalmitis." | 3.68 | The role of ciprofloxacin in endophthalmitis therapy. ( Eller, AW; Karenchak, LM; Kowalski, RP, 1993) |
| "Single intravitreal doses of ciprofloxacin, gentamicin, or imipenem were administered to rabbits with pseudomonas endophthalmitis for determination of the maximally effective dose." | 3.67 | Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections. ( Barza, M; Davey, PG; Stuart, M, 1987) |
| "Endogenous endophthalmitis is a rare condition caused by the hematogenous spread of microorganisms from a remote infection site to the eye." | 1.42 | Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis. ( de Haller, R; Mavrakanas, TA; Philippe, J, 2015) |
| "Ciprofloxacin eye drops were immediately discontinued and replaced by topical artificial tear substitute and tobramycin eye drop along with prednisolone acetate." | 1.40 | Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery. ( Mahadik, S; Vijay Zawar, S, 2014) |
| "Ciprofloxacin, 750 mg, was administered orally an average of 17 1/2 and 5 1/2 hours preoperatively." | 1.29 | The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. ( Ammann, H; Lamer, L; Lesk, MR; Marcil, G; Sebag, M; Vinet, B, 1993) |
| " We conclude that intravitreally injected ciprofloxacin may be a safe and useful antibiotic in the treatment of aminoglycoside-resistant bacterial endophthalmitis." | 1.28 | Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes. ( Basu, PK; Chisholm, L; Hasany, SM; Rootman, DS; Savage, P, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.64) | 18.7374 |
| 1990's | 16 (26.23) | 18.2507 |
| 2000's | 28 (45.90) | 29.6817 |
| 2010's | 13 (21.31) | 24.3611 |
| 2020's | 3 (4.92) | 2.80 |
| Authors | Studies |
|---|---|
| Asbell, PA | 1 |
| Sanfilippo, CM | 1 |
| Mah, FS | 1 |
| Feghhi, M | 1 |
| Sharif Makhmalzadeh, B | 1 |
| Farrahi, F | 1 |
| Akmali, M | 1 |
| Hasanvand, N | 1 |
| Tabuenca Del Barrio, L | 1 |
| Mozo Cuadrado, M | 1 |
| Compains Silva, E | 1 |
| Aliseda Pérez De Madrid, D | 1 |
| Heras Mulero, H | 1 |
| Tuñí-Picado, J | 1 |
| Martínez-Palmer, A | 1 |
| Fernández-Sala, X | 1 |
| Barceló-Vidal, J | 1 |
| Castilla-Martí, M | 1 |
| Cartagena-Guardado, Y | 1 |
| Grau, S | 1 |
| Pittman, HJ | 1 |
| Roy, R | 2 |
| Pradeep Kumar, P | 1 |
| Malathi, J | 2 |
| Swakshyar Saumya, P | 1 |
| Krishnendu, N | 1 |
| Abhinandan, P | 1 |
| Krustev, SZ | 1 |
| Rusenova, NV | 1 |
| Haritova, AM | 1 |
| Carron, A | 1 |
| Samudio, M | 1 |
| Laspina, F | 1 |
| Fariña, N | 1 |
| Sanabria, RR | 1 |
| Cibils, D | 1 |
| Ramirez, L | 1 |
| Carron, J | 1 |
| Mino de Kaspar, H | 1 |
| Vijay Zawar, S | 1 |
| Mahadik, S | 1 |
| Mavrakanas, TA | 1 |
| de Haller, R | 1 |
| Philippe, J | 1 |
| Tabatabaei, SA | 1 |
| Soleimani, M | 1 |
| Behrooz, MJ | 1 |
| Sheibani, K | 1 |
| Jensen, MK | 2 |
| Fiscella, RG | 2 |
| Moshirfar, M | 2 |
| Mooney, B | 2 |
| Lindstrom, RL | 1 |
| Holland, EJ | 1 |
| Lane, SS | 1 |
| McCulley, JP | 2 |
| Reddy, AK | 1 |
| Murthy, SI | 1 |
| Jalali, S | 1 |
| Gopinathan, U | 1 |
| Cardillo, JA | 1 |
| Paganelli, F | 1 |
| Melo, LA | 1 |
| Silva, AA | 1 |
| Pizzolitto, AC | 1 |
| Oliveira, AG | 1 |
| Irigoyen, C | 1 |
| Ziahosseini, K | 1 |
| Morphis, G | 1 |
| Stappler, T | 1 |
| Heimann, H | 1 |
| Batres Iglesias, AP | 1 |
| Pérez Cabeza, MI | 1 |
| Del Río Pardo, MJ | 1 |
| Castaño, M | 1 |
| Hooper, CY | 1 |
| Lightman, SL | 1 |
| Pacheco, P | 1 |
| Tam, PM | 1 |
| Khan, A | 1 |
| Taylor, SR | 1 |
| Panigrahi, P | 1 |
| Pal, SS | 1 |
| Nandi, K | 1 |
| Patil, A | 1 |
| Nigam, E | 1 |
| Arora, V | 1 |
| Ghazi-Nouri, SM | 1 |
| Lochhead, J | 1 |
| Mearza, AA | 1 |
| Qureshi, MA | 1 |
| Thompson, GM | 1 |
| Cowdrey, G | 1 |
| Firth, M | 1 |
| Moss, R | 1 |
| Karim, AK | 1 |
| Firth, G | 1 |
| Yao, K | 1 |
| Zhang, Z | 1 |
| Yang, YH | 1 |
| Wu, XD | 1 |
| García Serrano, JL | 1 |
| Domínguez, I | 1 |
| Serrano Laborda, D | 1 |
| Miller, D | 1 |
| Alfonso, EC | 1 |
| Vedantham, V | 3 |
| Crandall, AS | 1 |
| Wallin, T | 1 |
| Olson, RJ | 1 |
| Cheng, AC | 1 |
| Leung, DY | 1 |
| Rao, SK | 1 |
| Lam, DS | 1 |
| Freisberg, L | 1 |
| Starr, MB | 1 |
| Katz, HR | 1 |
| Chee, SP | 1 |
| Bacsal, K | 1 |
| Pathengay, A | 1 |
| Shah, GY | 1 |
| Das, T | 1 |
| Sharma, S | 1 |
| Yağci, R | 1 |
| Oflu, Y | 1 |
| Dinçel, A | 1 |
| Kaya, E | 1 |
| Yağci, S | 1 |
| Bayar, B | 1 |
| Duman, S | 1 |
| Bozkurt, A | 3 |
| Gupta, A | 1 |
| Srinivasan, R | 1 |
| Kaliaperumal, S | 1 |
| Setia, S | 1 |
| Yenerel, NM | 1 |
| Dinc, UA | 1 |
| Gorgun, E | 1 |
| Wolfensberger, TJ | 1 |
| Körner, F | 1 |
| Golnik, KC | 1 |
| Marotto, ME | 1 |
| Fanous, MM | 1 |
| Heitter, D | 1 |
| King, LP | 1 |
| Halpern, JI | 1 |
| Holley, PH | 1 |
| Hansen, EA | 1 |
| Stein, EA | 1 |
| Mader, TH | 1 |
| Mazzoli, RA | 1 |
| Kowalski, RP | 3 |
| Karenchak, LM | 2 |
| Eller, AW | 1 |
| Lesk, MR | 1 |
| Ammann, H | 1 |
| Marcil, G | 1 |
| Vinet, B | 1 |
| Lamer, L | 1 |
| Sebag, M | 1 |
| Braun, M | 1 |
| Jonas, JB | 1 |
| Schönherr, U | 1 |
| Naumann, GO | 1 |
| Kim, IT | 1 |
| Chung, KH | 1 |
| Koo, BS | 1 |
| Hainsworth, DP | 1 |
| Conklin, JD | 1 |
| Bierly, JR | 1 |
| Ax, D | 1 |
| Ashton, P | 1 |
| Alfaro, DV | 2 |
| Hudson, SJ | 1 |
| offele, JJ | 1 |
| Bevin, AA | 1 |
| Mines, M | 1 |
| Laughlin, RM | 1 |
| Schoderbek, RJ | 1 |
| Davis, J | 1 |
| Kim, S | 1 |
| Bia, F | 1 |
| Bogard, JF | 1 |
| Briggs, JW | 1 |
| Liggett, PE | 1 |
| Berman, AJ | 1 |
| Del Priore, LV | 1 |
| Fischer, CK | 1 |
| Okhravi, N | 1 |
| Towler, HM | 1 |
| Hykin, P | 1 |
| Matheson, M | 1 |
| Lightman, S | 1 |
| Oztürk, F | 2 |
| Kortunay, S | 2 |
| Kurt, E | 2 |
| Ilker, SS | 2 |
| Basci, NE | 2 |
| Horgan, SE | 1 |
| Matheson, MM | 1 |
| McLOUGHLIN-Borlace, L | 1 |
| Dart, JK | 1 |
| Murray, DC | 1 |
| Christopoulou, D | 1 |
| Hero, M | 1 |
| Inan, UU | 1 |
| Kadry, AA | 1 |
| Tawfik, AF | 1 |
| Abu El-Asrar, AA | 1 |
| Shibl, AM | 1 |
| Mohan, N | 1 |
| Gupta, V | 1 |
| Tandon, R | 1 |
| Gupta, SK | 1 |
| Vajpayee, RB | 1 |
| Price, LM | 1 |
| O'Mahony, C | 1 |
| Mather, R | 1 |
| Romanowski, EG | 1 |
| Keverline, MR | 1 |
| Dhaliwal, DK | 1 |
| Rootman, DS | 1 |
| Savage, P | 1 |
| Hasany, SM | 1 |
| Chisholm, L | 1 |
| Basu, PK | 1 |
| Davey, PG | 1 |
| Barza, M | 1 |
| Stuart, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endophthalmitis Post Intravitreal Injections Comparison EPIIC Trial: Pars Plana Vitrectomy Versus Tap and Inject[NCT04035369] | 310 participants (Anticipated) | Interventional | 2020-03-01 | Recruiting | |||
| Intracameral Levofloxacin (0.5%) Versus Intracameral Cefuroxime (1mg/0.1ml) Effect on Corneal Endothelial Cell Count and Morphology in Uneventful Phacoemulsification[NCT04212078] | Phase 1/Phase 2 | 138 participants (Anticipated) | Interventional | 2019-07-29 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ciprofloxacin and Endophthalmitis
| Article | Year |
|---|---|
[Efficacy of topical 0.3% ciprofloxacin application in reducing the conjunctival biota of patients undergoing cataract extraction].
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Bacteria; | 2013 |
[Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin].
Topics: Administration, Topical; Aged; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Female; Humans; Male; | 2003 |
Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial.
Topics: Administration, Topical; Anti-Infective Agents; Cataract Extraction; Ciprofloxacin; Dexamethasone; D | 2001 |
58 other studies available for ciprofloxacin and Endophthalmitis
| Article | Year |
|---|---|
Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) Surveillance Study: 2009-2020 update.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthal | 2022 |
Anti-microbial Effect and in Vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit's Eye.
Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Aqueous Humor; Area Under Curve; Biological Availabi | 2020 |
Haemophilus Influenzae Endogenous Endophthalmitis in an Immunocompetent Host.
Topics: Adolescent; Anti-Bacterial Agents; Cataract Extraction; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug | 2021 |
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azi | 2018 |
A 49-Year-Old Male Private Snake Keeper With Venom-Spit Ophthalmia.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Emergency Nursing; Endophthalmitis; Humans; Male; Mid | 2019 |
Endophthalmitis caused by Citrobacter species: a case series.
Topics: Aged; Anti-Bacterial Agents; Child; Ciprofloxacin; Citrobacter; Endophthalmitis; Enterobacteriaceae | 2013 |
Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Anti-Bacterial Agents; Anti-Inflammatory Age | 2014 |
Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Cataract Extraction; Chemical Precipitation; C | 2014 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmit | 2015 |
SYSTEMIC ORAL ANTIBIOTICS AS A PROPHYLACTIC MEASURE TO PREVENT ENDOPHTHALMITIS IN PATIENTS WITH OPEN GLOBE INJURIES IN COMPARISON WITH INTRAVENOUS ANTIBIOTICS.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic | 2016 |
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprof | 2008 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye In | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye In | 2009 |
Post-operative endophthalmitis due to an unusual pathogen, Comamonas testosteroni.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Ciprofloxacin; Comamonas | 2009 |
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Aqueous Humor; Bio | 2010 |
Endophthalmitis following intravitreal injections.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Aqueous Humor; Bacteria; Ci | 2012 |
[Endogenous endophthalmitis as a first clinical manifestation of Klebsiella sepsis. The importance of an early diagnosis].
Topics: Anti-Bacterial Agents; Bacteremia; Chorioretinitis; Choroid Hemorrhage; Ciprofloxacin; Combined Moda | 2011 |
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; | 2012 |
Endophthalmitis caused by Acinetobacter baumanni: a case series.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Infective Agents; Cataract Extraction; | 2013 |
Penetration of oral and topical ciprofloxacin into the aqueous humour.
Topics: Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Anti-Infective Agents; Antib | 2003 |
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Th | 2004 |
Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Endophthalmitis; Humans; Keratitis; Levofloxacin; Microbial Se | 2004 |
Ciprofloxacin in endophthalmitis: an emerging alternative.
Topics: Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combina | 2004 |
Much ado about ciprofloxacin and Acinetobacter.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Aqueous Humor; Ciprofl | 2004 |
A retrospective study of endophtalmitis rates comparing quinolone antibiotics.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross | 2005 |
Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Endophthalmitis; | 2005 |
A population pharmacokinetic-metabolism model for individualizing ciprofloxacin therapy in ophthalmology.
Topics: Administration, Oral; Administration, Topical; Animals; Aqueous Humor; Cataract Extraction; Ciproflo | 2005 |
Low acute endophthalmitis rate: possible explanations.
Topics: Acute Disease; Anti-Infective Agents; Antibiotic Prophylaxis; Cataract Extraction; Ciprofloxacin; En | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
Endophthalmitis after microincision cataract surgery.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Ba | 2005 |
Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Therapy, Combinati | 2006 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; | 2007 |
Microbial cultures in open globe injuries in southern India.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Ciprofloxacin; Endophthalmitis; Eye Infections, | 2007 |
A case of sterile endophthalmitis after repeated intravitreal bevacizumab injection.
Topics: Angiogenesis Inhibitors; Angioid Streaks; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodie | 2008 |
[Change in therapy of acute endophthalmitis: an analysis of 92 cases 1980-1993].
Topics: Acute Disease; Cataract Extraction; Ciprofloxacin; Combined Modality Therapy; Endophthalmitis; Follo | 1995 |
Ophthalmic manifestations of Rochalimaea species.
Topics: Adolescent; Adult; Alphaproteobacteria; Antibodies, Bacterial; Bartonella Infections; Ciprofloxacin; | 1994 |
Spitting cobra ophthalmia in United Nations Forces in Somalia.
Topics: Adult; Animals; Anterior Eye Segment; Ciprofloxacin; Elapid Venoms; Endophthalmitis; Humans; Male; M | 1994 |
The role of ciprofloxacin in endophthalmitis therapy.
Topics: Bacteria; Ciprofloxacin; Colony Count, Microbial; Endophthalmitis; Eye Infections, Bacterial; Humans | 1993 |
The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.
Topics: Administration, Oral; Aqueous Humor; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; | 1993 |
Ochrobactrum anthropi endophthalmitis after uncomplicated cataract surgery.
Topics: Aged; Alcaligenes; Anterior Chamber; Anti-Infective Agents; Cataract Extraction; Ciprofloxacin; Endo | 1996 |
Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Dexamethasone; Disease Mode | 1996 |
Intravitreal delivery of ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Delayed-Action Preparations; Drug Deli | 1996 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Cipr | 1996 |
Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Bacillaceae Infections; Ciprofloxacin; Disease Models, Animal; Endop | 1996 |
Endogenous Ochrobactrum anthropi endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Cat | 1997 |
Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combin | 1997 |
Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Ciprof | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithro | 1999 |
Intravitreal penetration of teicoplanin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Compounding; Endophthalmitis; Eye | 1999 |
The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Endophthalmit | 2000 |
Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Ciprofloxacin; Clindamycin; Conju | 2001 |
Gonococcal ophthalmia treated with ciprofloxacin.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Endophth | 2001 |
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophtha | 2002 |
In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteria; Ciprofloxacin | 2002 |
Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes.
Topics: Animals; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Injections; Ophth | 1992 |
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
Topics: Animals; Ciprofloxacin; Dose-Response Relationship, Drug; Endophthalmitis; Gentamicins; Imipenem; Ps | 1987 |